SF Healthcare Week: Insmed CEO Will Lewis discusses the launch BRINSUPRI and pipeline readouts ahead in 2026
Jan 14, 2026
09:10
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
He discusses the $145M 4Q number that was announced at JPM, and the real world feedback the company has been receiving from physicians and patients. Plus, how the thinks about Insmed now that it is a $35B market cap company.
BiotechTV - News